The ACME Laboratories Ltd. reported unaudited earnings results for the third quarter and year to date ended March 31, 2018. EPS was BDT 1.85 for January-March 2018 as against BDT 1.82 for January-March 2017. EPS was BDT 5.66 for July 2017-March 2018 as against BDT 5.42 for July 2016-March 2017. NOCFPS was BDT 6.80 for July 2017-March 2018 as against BDT 5.18 for July 2016-March 2017. NAV per share was BDT 82.32 as on March 31, 2018 and BDT 80.13 as on June 30, 2017.